Despite the alluring potential, the majority of global pharmaceutical companies have not been able to establish a stable position in emerging markets; only 10 to 20 percent of multinational corporations' total income comes from developing nations.
Otsuka Pharmaceutical Co., Ltd. and ShapeTX, a programmable medicine company that uses AI and RNA to cure genetic diseases, announced a multi-target collaboration to develop intravitreally-delivered adeno-associated viruses (AAVs) for ocular diseases
Pharmaceutical item distribution must be effective and seamless in order for patients to obtain the pharmaceuticals they require when they need them.
Mitsubishi Electric Corporation, Okayama University and Osaka University’s Graduate School of Engineering announced that they have developed a magnetic particle imaging device capable of sensitive imaging of magnetic particles in an area...
Lupin Limited (Lupin) has formed a unique partnership with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), a pioneer in cheap pharmaceuticals, and the COPD Foundation, which is dedicated to improving the lives of COPD sufferers....
Fujifilm India, a pioneer in healthcare imaging and information systems formalized their partnership with department of gastroenterology, Yashoda Group of Hospitals, Hyderabad for establishing training and research facility...
According to Poonam Khetrapal Singh, Regional Director, World Health Organisation (WHO) South-East Asia, India's G20 presidency has identified three health priorities: strengthening global health infrastructure, delivering health, and providing...
Notwithstanding the fact that the country’s pharmaceutical (pharma) pricing regulator has allowed a 12 per cent price increase for medicines listed under the National List of Essential Medicines (NLEM) in 2023, analysts and industry insiders...
Cytecare Hospitals, one of India's healthcare leaders, has launched a state-of-the-art Nephrology Institute in collaboration with Humanist Centre for Medicine (Humanist), a Bengaluru-based NGO that aims to bridge funding gaps for patients....
In an effort to address the concerns raised from time to time regarding the quality, safety and efficacy of the drugs and uniform implementation of the provisions of the regulations, the central drug regulator has been contemplating a comprehensive..
, CDSCO.jpg)
.jpg)